原发性晚期与复发性卵巢恶性肿瘤完全减瘤术中的大血管切除:病例系列与文献系统综述——推动肿瘤血管外科的边界
该研究回顾性分析2021年1月至2023年维罗纳大学妇产科减瘤术中至少切除一根大血管的卵巢癌患者,并系统检索Pubmed和Embase至2023年1月报告同类病例。本机构5例均获R0,3例(60%)出现术后并发症;文献检索到7例,4例(57.1%)出现并发症;12例中66.7%末次随访无病生存(中位15.5个月,范围5-25)。作者认为肿瘤血管外科在选定患者中可行,需多学科个体化诊疗。
要点
- 本机构5例晚期/复发卵巢癌大血管切除均获R0,3例(60%)出现术后并发症。
- 文献检索到7例卵巢癌大血管切除,4例(57.1%)出现术后并发症。
- 12例合计66.7%末次随访无病生存,中位随访15.5个月(范围5-25)。
核心结论
- 作者认为,在具备多学科个体化诊疗的条件下,肿瘤血管外科在选定卵巢癌患者中可行。
研究设计与样本
- 回顾性分析2021年1月至2023年维罗纳大学妇产科卵巢癌减瘤手术患者数据库,识别减瘤术中至少切除一根大血管者。
- 系统检索Pubmed和Embase自建库至2023年1月,报告卵巢癌手术合并大血管切除的所有病例。
主要发现
- 本机构5例晚期/复发卵巢癌行大血管切除,所有病例术前识别血管受累,无意外损伤后行血管切除者。
- 切除的大血管包括下腔静脉(n=2)、髂总静脉(n=2)、髂外动脉(n=2)、左髂总动脉(n=1)、左髂外静脉(n=1)。
- 本机构所有患者均在血管切除前接受其他非妇科减瘤操作,且均获R0;3例(60%)出现一次或多次术后并发症。
- 文献检索到7例卵巢癌手术大血管切除,2例(28.6%)切除单根大血管、5例(72.4%)切除多根大血管,7例均行血管重建,4例(57.1%)报告术后并发症。
- 12例合计中66.7%末次随访无病生存,中位随访15.5个月(范围5-25)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Oncovascular surgery (the removal of major blood vessels infiltrated by cancer) is challenging but can be key to achieve complete cytoreduction in patient with advanced ovarian cancer. The aim of this study was to review the literature on oncovascular surgery in ovarian cancer and to report the details of all the cases performed at our institution. METHODS: We retrospectively reviewed the database of ovarian cancer patients who underwent debulking surgery at the Department of Obstetrics and Gynecology of Verona University between January 2021 and 2023. Patients with at least one major vessel resection during cytoreduction were identified. We then systematically review the literature searching Pubmed and Embase from inception to January 2023 to report all cases of surgery for ovarian cancer with concomitant major vessel resection. RESULTS: Five patients with advanced/recurrent ovarian cancer underwent major vascular resection at our institution. Vascular involvement was preoperatively identified in all cases and no case of vascular resection was performed after accidental injury. The major vessels removed were the inferior vena cava (n = 2), the common iliac veins (n = 2), the external iliac arteries (n = 2), the left common iliac artery (n = 1), and the left external iliac vein (n = 1). All patients underwent other non-gynecological cytoreductive procedures prior to vessel removal and had R0 obtained. Three (60%) patients experienced one or more postoperative complications. The literature search identified a total of seven cases of major vessels resection in ovarian cancer surgery. A single or multiple major vessels were removed in two (28.6%) and five (72.4%) cases, respectively. All the seven patients underwent vascular reconstruction. Four (57.1%) patients reported postoperative complications. Overall, 66.7% of the 12 total identified patients were free from disease at the last follow-up [median 15.5 months (range 5-25)]. CONCLUSIONS: Oncovascular surgery is feasible in selected patients with ovarian cancer, provided that a multidisciplinary approach with customized care is available.
引用
- Uccella S, Bosco M, Mezzetto L, et al. Major vessel resection for complete cytoreduction in primary advanced and recurrent ovarian malignancies: A case series and systematic review of the literature - pushing the boundaries in oncovascular surgery. Gynecol Oncol. 2023. PMID: 37922861. doi:10.1016/j.ygyno.2023.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。